SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of acquisition of beneficial ownership by individuals [amend]
SEC Accession No. 0001319244-12-000004
Filing Date
2012-02-07
Accepted
2012-02-07 17:28:01
Documents
1
Filing Date Changed
2012-02-07
Group Members
COGNIZANT HOLDINGS, LTD.ICS OPPORTUNITIES, LTD.INTEGRATED ASSETS, LTD.ISRAEL A. ENGLANDERMILLENCO LLCMILLENNIUM INTERNATIONAL MANAGEMENT GP LLCMILLENNIUM INTERNATIONAL MANAGEMENT LPMILLENNIUM MANAGEMENT LLC

Document Format Files

Seq Description Document Type Size
1 amag_sc13g-a1.htm SC 13G/A 168184
  Complete submission text file 0001319244-12-000004.txt   170262
Mailing Address 100 HAYDEN AVENUE LEXINGTON MA 02421
Business Address 100 HAYDEN AVENUE LEXINGTON MA 02421 6174983300
AMAG PHARMACEUTICALS INC. (Subject) CIK: 0000792977 (see all company filings)

IRS No.: 042742593 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-38286 | Film No.: 12578867
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1

Mailing Address C/O MILLENNIUM MANAGEMENT LLC 666 FIFTH AVENUE, 8TH FLOOR NEW YORK NY 10103
Business Address C/O MILLENNIUM MANAGEMENT LLC 666 FIFTH AVENUE, 8TH FLOOR NEW YORK NY 10103 (212) 841-4100
INTEGRATED CORE STRATEGIES (US) LLC (Filed by) CIK: 0001319244 (see all company filings)

IRS No.: 202196675 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A